Umoja Biopharma | $100,000,000 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
r4 | $1,000,000 | (Jan 21, 2025)
Certified by Founder
Lodge
Genesis Global
start up
United Kingdom
- London, London
- 16/02/2022
- Series C
- $200,000,000
Genesis enables financial market organizations to innovate at speed through our low-code platform that supercharges developers to build resilient, performant and secure applications with unmatched efficiency and scale.
Genesis provides freedom from legacy and replaces the buy vs. build challenge with a buy-to-build solution.
With years of financial markets and technical expertise, the Genesis team understands how financial markets organizations need to innovate their products, services and applications with speed and agility to maintain a competitive edge. Strategically backed by Citi and trusted by B3, ING and London Clearinghouse, Genesis has global offices in New York (HQ), Miami, London, São Paulo, and Dublin.
- Industry Financial Services
- Website https://new.genesis.global/
- LinkedIn https://www.linkedin.com/company/genesis-global-technology/about/
IntusCare | $11,500,000 | (Jan 21, 2025)
Alteva Technologies | $1,760,526 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
StepChange.work | $4,000,000 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)
Pipe17 | $15,500,000 | (Jan 17, 2025)
Coram AI | $13,800,000 | (Jan 17, 2025)
Quantifind | $22,000,000 | (Jan 17, 2025)